Protein Metabolism Disorders and Hemostasis System
Liver damage directly impacts a critical function of hepatocytes: their synthetic capability. As these processes become suppressed, the systemic production of various specialized proteins drops sharply, which critically affects the blood coagulation cascade.
First, the production of coagulation proteins declines. These essential procoagulants include:
- Fibrinogen (Factor I);
- Prothrombin (Factor II);
- Proaccelerin (Factor V);
- Proconvertin (Factor VII);
- Christmas factor (Factor IX);
- Stuart-Prower factor (Factor X).
In addition to procoagulant factors, the liver synthesizes anticoagulant proteins, such as proteins C and S. Their deficiency also disrupts hemostasis.
Clinical manifestation: A drop in the plasma concentration of these proteins predictably leads to hypocoagulation. Externally and internally, this manifests as dangerous hemorrhagic diathesis, a tendency toward prolonged bleeding, and hematoma formation.
Vitamin Metabolism Disorders
The liver acts as the primary biochemical laboratory where inactive vitamin precursors are converted into active molecules. In hepatic failure, this process is blocked at two main levels.
- Decreased provitamin transformation: Hepatocytes lose their ability to efficiently convert dietary precursors into active forms. A classic example is the impaired biochemical conversion of $\beta$-carotene into functional vitamin A.
- Inhibition of coenzyme formation: Vitamins, particularly the B group, must undergo activation to become parts of enzymatic systems. Hepatic pathology suppresses the synthesis of:
- Thiamine pyrophosphate (synthesized from vitamin $B_1$);
- Flavin mononucleotide and flavin adenine dinucleotide (formed from vitamin $B_2$);
- Pyridoxal-5-phosphate (derived from vitamin $B_6$);
- Coenzyme A (formed from pantothenic acid).
The absence of these cofactors triggers a cascade of secondary metabolic disruptions because enzymes dependent on these active groups halt their activity.
Mineral Metabolism Alterations
In liver failure, mineral metabolism undergoes substantial and highly diverse disorders. The metabolism of trace elements such as iron, copper, and chromium is primarily affected.
A striking clinical example linking liver pathology to mineral imbalance is hereditary hemochromatosis. In this condition, iron abnormally accumulates directly within liver tissues. Excess metal exerts a toxic effect on cells, which inevitably leads to organ enlargement (hepatomegaly) and the development of cirrhosis over time.